Rubinstein-Taybi syndrome

Clinical trials for Rubinstein-Taybi syndrome explained in plain language.

Never miss a new study

Get alerted when new Rubinstein-Taybi syndrome trials appear

Sign up with your email to follow new studies for Rubinstein-Taybi syndrome, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Completed 1

Can a common drug boost brain function in kids with rare genetic disorder?

Disease control Completed

This phase 2 trial tested sodium valproate, a drug used for seizures, in 41 children with Rubinstein-Taybi syndrome (RTS), a rare genetic condition causing intellectual disability. Participants aged 6 to 21 received either the drug or a placebo for one year. Researchers measured …

Matched conditions: RUBINSTEIN-TAYBI SYNDROME

Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

Rubinstein-Taybi syndrome

Get alerted when new Rubinstein-Taybi syndrome trials appear

Can a common drug boost brain function in kids with rare genetic disorder?